← Back to headlines
Medtronic's MiniMed Diabetes Unit Eyes $7.9 Billion Valuation in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking a valuation of $7.9 billion as it prepares for a US initial public offering.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
With surge in fuel cost, Agusan Sur trike drivers’ income drop by half
just now
Filipino Worker Returns Home from Kuwait Amid Middle East Tensions
just now
Philippines Addresses Oil Crisis with Fuel Aid for Fishers Amid Rising Costs
just now
Philippines Debates 'Bayanihan 3' Bill Amid Fuel Price Crisis
just now